Financhill
Back

Edgewise Therapeutics Quote, Financials, Valuation and Earnings

Edgewise Therapeutics Price Quote

$19.05
+0.98 (+5.39%)
(Updated: September 18, 2024 at 6:55 PM ET)

Edgewise Therapeutics Key Stats

Sell
48
Edgewise Therapeutics (EWTX) is a Sell

Day range:
$17.00 - $19.84
52-week range:
$5.12 - $23.50
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
3.32%

Volume:
2.9M
Avg. volume:
831.3K
1-year change:
181.54%
Market cap:
$1.7B
Revenue:
$0
EPS:
$-1.55

How Much Does Edgewise Therapeutics Make?

Data Unavailable

Is Edgewise Therapeutics Growing As A Company?

Data Unavailable

Edgewise Therapeutics Stock Price Performance

What Is Edgewise Therapeutics 52-Week High & Low?

Edgewise Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Edgewise Therapeutics?

Is Edgewise Therapeutics Cash Flow Positive?

  • What Is EWTX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$103.6M
  • What Is Edgewise Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $295.8M
  • What Is Edgewise Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$180.5M

Edgewise Therapeutics Return On Invested Capital

Data Unavailable

Edgewise Therapeutics Earnings Date & Stock Price

Edgewise Therapeutics Competitors

Edgewise Therapeutics Dividend Yield

Edgewise Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0.6%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 33.17
Upside from Last Price: 83.49%

Major Shareholders

  • How many EWTX shares are owned by institutional investors?
    144M EWTX shares are owned by institutional investors
  • How many EWTX shares are owned by insiders?
    139.8K EWTX shares are owned by insiders